Table 5 provides a detailed overview of the longitudinal changes in C-reactive protein levels and Disease Activity Score in 28 joints using C-reactive protein in patients with rheumatoid arthritis and psoriatic arthritis. This evidence concerns the gene CRP and rheumatoid arthritis.